Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin.
Brown AS, Bakker-Arkema RG, Yellen L, Henley RW Jr, Guthrie R, Campbell CF, Koren M, Woo W, McLain R, Black DM. Brown AS, et al. Among authors: mclain r. J Am Coll Cardiol. 1998 Sep;32(3):665-72. doi: 10.1016/s0735-1097(98)00300-3. J Am Coll Cardiol. 1998. PMID: 9741509 Free article. Clinical Trial.
The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin.
Koren MJ, Smith DG, Hunninghake DB, Davidson MH, McKenney JM, Weiss SR, Schrott HG, Henley RW Jr, Tresh P, McLain RW, Bakker-Arkema RG, Black DM. Koren MJ, et al. Among authors: mclain rw. Pharmacoeconomics. 1998 Jul;14(1):59-70. doi: 10.2165/00019053-199814010-00006. Pharmacoeconomics. 1998. PMID: 10182195 Clinical Trial.
A Multicenter, Placebo-Controlled, Dose-Ranging Study of Atorvastatin.
Schrott H, Fereshetian AG, Knopp RH, Bays H, Jones PH, Littlejohn TW 3rd, McLain R, Black DM. Schrott H, et al. Among authors: mclain r. J Cardiovasc Pharmacol Ther. 1998 Apr;3(2):119-124. doi: 10.1177/107424849800300204. J Cardiovasc Pharmacol Ther. 1998. PMID: 10684489
The safety and tolerability of quinapril.
Knapp LE, Frank GJ, McLain R, Rieger MM, Posvar E, Singer R. Knapp LE, et al. Among authors: mclain r. J Cardiovasc Pharmacol. 1990;15 Suppl 2:S47-55. doi: 10.1097/00005344-199000152-00009. J Cardiovasc Pharmacol. 1990. PMID: 1691407 Clinical Trial.
Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions.
Tardif JC, Grégoire J, L'Allier PL, Anderson TJ, Bertrand O, Reeves F, Title LM, Alfonso F, Schampaert E, Hassan A, McLain R, Pressler ML, Ibrahim R, Lespérance J, Blue J, Heinonen T, Rodés-Cabau J; Avasimibe and Progression of Lesions on UltraSound (A-PLUS) Investigators. Tardif JC, et al. Among authors: mclain r. Circulation. 2004 Nov 23;110(21):3372-7. doi: 10.1161/01.CIR.0000147777.12010.EF. Epub 2004 Nov 8. Circulation. 2004. PMID: 15533865 Clinical Trial.
162 results